Allianz Asset Management GmbH Purchases 288,783 Shares of Sabra Healthcare REIT, Inc. $SBRA

Allianz Asset Management GmbH raised its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 54.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 821,705 shares of the real estate investment trust's stock after purchasing an additional 288,783 shares during the period. Allianz Asset Management GmbH owned 0.35% of Sabra Healthcare REIT worth $15,152,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. SG Americas Securities LLC lifted its holdings in Sabra Healthcare REIT by 7.5% during the 1st quarter. SG Americas Securities LLC now owns 23,588 shares of the real estate investment trust's stock worth $412,000 after purchasing an additional 1,647 shares in the last quarter. Wealth Enhancement Advisory Services LLC purchased a new stake in Sabra Healthcare REIT during the 1st quarter worth about $180,000. Janney Montgomery Scott LLC lifted its holdings in Sabra Healthcare REIT by 2.9% during the 1st quarter. Janney Montgomery Scott LLC now owns 182,328 shares of the real estate investment trust's stock worth $3,185,000 after purchasing an additional 5,167 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in Sabra Healthcare REIT by 1.5% during the 1st quarter. State of Alaska Department of Revenue now owns 142,348 shares of the real estate investment trust's stock worth $2,486,000 after purchasing an additional 2,136 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Sabra Healthcare REIT by 4.7% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock worth $331,000 after purchasing an additional 853 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Price Performance

NASDAQ:SBRA opened at $18.43 on Tuesday. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of 24.25, a P/E/G ratio of 1.22 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The stock has a fifty day moving average of $18.68 and a 200 day moving average of $18.20. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter last year, the business posted $0.36 earnings per share. The company's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.5%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on SBRA shares. Truist Financial increased their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a report on Tuesday, September 2nd. BMO Capital Markets lifted their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday, August 25th. Wells Fargo & Company lifted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. JMP Securities lifted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. Finally, Scotiabank lifted their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $20.88.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.